We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

115 hedge funds and large institutions have $244M invested in BioTelemetry, Inc. in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 45 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $395K

3% less capital invested

Capital invested by funds: $250M → $244M (-$6.59M)

3% less funds holding

Funds holding: 119115 (-4)

20% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 20

24% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 45

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
115
Holders Change
-4
Holders Change %
-3.36%
% of All Funds
3.02%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.1%
New
16
Increased
34
Reduced
45
Closed
20
Calls
$1.37M
Puts
$395K
Net Calls
+$974K
Net Calls Change
-$1.18M
Name Holding Trade Value Shares
Change
Change in
Stake
TCM
26
Timpani Capital Management
Wisconsin
$2.52M -$155K -12,243 -5%
MAG
27
Millrace Asset Group
Pennsylvania
$2.5M +$111K +8,752 +4%
EI
28
EAM Investors
California
$2.42M -$548K -43,314 -17%
KI
29
Kalmar Investments
Delaware
$2.35M -$2.08M -164,199 -45%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$2.33M +$1.16M +91,715 +85%
BCM
31
Bridgeway Capital Management
Texas
$2.26M -$221K -17,500 -8%
SCM
32
Sio Capital Management
New York
$2.24M +$2.43M +191,755 New
PAM
33
Panagora Asset Management
Massachusetts
$2.17M +$323K +25,540 +16%
Geode Capital Management
34
Geode Capital Management
Massachusetts
$2.03M -$253K -20,019 -10%
ACP
35
Acuta Capital Partners
California
$1.76M -$3.79M -299,678 -67%
AIC
36
AWM Investment Company
New York
$1.69M
BIM
37
Bogle Investment Management
Massachusetts
$1.63M -$2.84M -224,160 -62%
Citadel Advisors
38
Citadel Advisors
Florida
$1.58M -$132K -10,451 -7%
TA
39
Teton Advisors
New York
$1.58M +$356K +28,100 +26%
AQR Capital Management
40
AQR Capital Management
Connecticut
$1.57M +$1.03M +81,062 +151%
PIM
41
Platinum Investment Management
Australia
$1.52M
Bank of America
42
Bank of America
North Carolina
$1.5M -$57.5K -4,546 -3%
GC
43
Globeflex Capital
California
$1.49M -$27.8K -2,200 -2%
PCM
44
Perkins Capital Management
Minnesota
$1.39M +$324K +25,600 +27%
AI
45
Analytic Investors
California
$1.38M +$638K +50,446 +74%
RHJA
46
Rice Hall James & Associates
California
$1.38M +$1.49M +117,940 New
GPCM
47
Granite Point Capital Management
Massachusetts
$1.26M -$152K -12,000 -10%
GF
48
Gabelli Funds
New York
$1.19M +$1.29M +101,847 New
BIM
49
BlackRock Investment Management
Delaware
$1.11M +$2.71K +214 +0.2%
TCIM
50
TIAA CREF Investment Management
New York
$1.01M -$37.7K -2,981 -3%

BEAT Hedge Fund Activity: Q4 2015 in Review

115 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q4 2015, worth a combined $244M — down 2.6% from $250M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of BEAT and 16 opened new positions — a net loss of 4 holders — while 45 trimmed existing stakes and 34 added.

The largest buyer was Thompson Siegel & Walmsley, opening a new position worth an estimated $13.3M. The largest seller was Deutsche Bank, cutting an estimated $4.02M.

  • 115 institutional investors held BioTelemetry, Inc. (BEAT) as of Q4 2015, down from 119 in Q3 2015.
  • Funds reported $244M of BioTelemetry, Inc. stock for Q4 2015, down 2.6% quarter-over-quarter.
  • 16 funds opened new BioTelemetry, Inc. positions in Q4 2015 and 20 closed out, a net change of -4 holders.
  • The largest BioTelemetry, Inc. buyer in Q4 2015 was Thompson Siegel & Walmsley, an estimated $13.3M added.
  • The largest BioTelemetry, Inc. seller in Q4 2015 was Deutsche Bank, an estimated $4.02M sold.

Based on aggregated 13F filings for Q4 2015.